Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2024-03-21 00:00:00 ET · period of report 2024-03-20 · accession 0001415889-24-008881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-21 | 2024-03-20 | CTKB | Busque Philippe | SVP, Gbl SALES AND SERVICES | M - OptEx | — | +5,464 | 5,464 | New | — |
| D | 2024-03-21 | 2024-03-20 | CTKB | Busque Philippe | SVP, Gbl SALES AND SERVICES | F - Tax | $6.70 | -2,129 | 3,335 | -39% | -$14.3K |
| D | 2024-03-21 | 2024-03-20 | CTKB | Busque Philippe | SVP, Gbl SALES AND SERVICES | M - OptEx | $0.00 | -5,464 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-20 | M | A | 5,464 | — | 5,464 | D | — | — | (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2024-03-20 | F | D | 2,129 | $6.70 | 3,335 | D | — | — | (F2) Represents the number of shares withheld by and surrendered to the Issuer on March 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award. |
| 3 | Derivative | Restricted Stock Units | 2024-03-20 | M | D | 5,464 | $0.00 | 0 | D | — · — to — | 5,464 Common Stock | (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares subject to the RSU Award vested on March 20, 2024. |